Your browser is no longer supported. Please, upgrade your browser.
Settings
SGYP Synergy Pharmaceuticals Inc. daily Stock Chart
SGYP [NASD]
Synergy Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.16 Insider Own0.20% Shs Outstand252.97M Perf Week-28.31%
Market Cap493.29M Forward P/E- EPS next Y-0.69 Insider Trans-94.69% Shs Float223.03M Perf Month-30.85%
Income-247.20M PEG- EPS next Q-0.22 Inst Own62.40% Short Float30.89% Perf Quarter-35.00%
Sales7.40M P/S66.66 EPS this Y-8.50% Inst Trans-6.93% Short Ratio10.62 Perf Half Y-50.38%
Book/sh-0.01 P/B- EPS next Y36.10% ROA-195.90% Target Price7.75 Perf Year-64.22%
Cash/sh- P/C- EPS next 5Y- ROE-540.20% 52W Range1.68 - 7.15 Perf YTD-67.98%
Dividend- P/FCF- EPS past 5Y-31.80% ROI- 52W High-72.73% Beta1.39
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin7.60% 52W Low16.07% ATR0.23
Employees116 Current Ratio4.30 Sales Q/Q- Oper. Margin- RSI (14)28.99 Volatility15.87% 8.90%
OptionableYes Debt/Eq- EPS Q/Q2.90% Profit Margin- Rel Volume1.22 Prev Close2.00
ShortableYes LT Debt/Eq- EarningsNov 09 AMC Payout- Avg Volume6.49M Price1.95
Recom2.00 SMA20-26.57% SMA50-30.87% SMA200-50.77% Volume7,940,323 Change-2.50%
Sep-25-17Reiterated H.C. Wainwright Buy $15 → $8
Sep-13-17Reiterated Citigroup Sell $3.20 → $2.50
Sep-08-17Reiterated Oppenheimer Outperform $9 → $6
Aug-10-17Reiterated Rodman & Renshaw Buy $18 → $15
Apr-06-17Downgrade Citigroup Neutral → Sell
Jan-20-17Reiterated Rodman & Renshaw Buy $17 → $18
Jan-05-17Initiated Oppenheimer Outperform
Dec-23-16Reiterated Rodman & Renshaw Buy $16 → $17
Dec-18-15Downgrade Citigroup Buy → Neutral
Oct-29-15Resumed ROTH Capital Buy $9.50
Jun-18-15Reiterated Canaccord Genuity Buy $11 → $19
May-22-15Initiated Canaccord Genuity Buy $11
Nov-18-14Reiterated ROTH Capital Buy $8.50 → $6
Aug-12-13Reiterated Cantor Fitzgerald Buy $15 → $11
Apr-09-13Reiterated Cantor Fitzgerald Buy $12 → $15
Jan-02-13Reiterated Cantor Fitzgerald Buy $7 → $13
Sep-25-12Initiated Cantor Fitzgerald Buy $7
Nov-17-17 08:05AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-15-17 12:50PM  Synergy Pharmaceuticals: Should You Buy the Dip Ahead of FDA Approval? SmarterAnalyst -6.90%
08:05AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-14-17 02:54PM  Here's What's Behind Synergy Pharmaceuticals' 15.6% Drop Today Motley Fool -16.80%
12:31AM  Edited Transcript of SGYP earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-17 10:47AM  BTIG Suggests One Stock to Buy and One to Proceed with Caution SmarterAnalyst -10.29%
09:27AM  Synergy Pharmaceuticals Announces Pricing of Offering of Common Stock and Warrants Business Wire
08:10AM  Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE
Nov-12-17 12:00PM  5 Small Biotechs Receive Shots in the Arm TheStreet.com
Nov-10-17 01:32PM  Canaccords Confident Take: Synergy Pharmaceuticals Could See Exciting Commercial Potential Boost Come 2018 SmarterAnalyst -8.42%
08:13AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-09-17 06:18PM  Synergy Pharma reports 3Q loss Associated Press
04:00PM  Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results and Business Update Business Wire
12:30PM  Synergy Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 08:20AM  Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
07:16AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : November 6, 2017 Capital Cube
Nov-01-17 08:30AM  Synergy Pharmaceuticals to Report Third Quarter 2017 Financial Results and Host Conference Call and Webcast Business Wire
Oct-26-17 12:24PM  Synergy Pharmaceuticals Inc (SGYP): A 2018 Story Shapes Up SmarterAnalyst
Oct-25-17 11:36AM  3 Biotech Stocks to Consider Ahead of FDA Decisions Investopedia
Oct-19-17 08:15AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : October 19, 2017 Capital Cube
Oct-18-17 02:20PM  H.C. Wainwright Pounds the Table on Synergy Pharmaceuticals Inc (SGYP) SmarterAnalyst
Oct-17-17 10:30AM  Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Oct-12-17 09:30AM  Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (Plecanatide) at the World Congress of Gastroenterology (WCOG) at American College of Gastroenterology (ACG) Business Wire
Oct-04-17 11:27AM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : October 4, 2017 Capital Cube +6.50%
Oct-03-17 08:33AM  Synergy Pharmaceuticals (SGYP) Surges: Stock Moves 12.1% Higher Zacks
08:15AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : October 3, 2017 Capital Cube
Oct-02-17 08:06AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit +12.07%
08:00AM  Today's Research Reports on Trending Tickers: Synergy Pharmaceuticals and Jaguar Health ACCESSWIRE
Sep-29-17 05:15PM  Why Synergy Pharmaceuticals Rallied 12% Today Motley Fool +11.97%
Sep-26-17 01:43PM  Analysts Take Action on Health Care Stocks GuruFocus.com
08:04AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Sep-21-17 07:54PM  CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
Sep-08-17 09:45PM  Edited Transcript of SGYP earnings conference call or presentation 7-Sep-17 8:30pm GMT Thomson Reuters StreetEvents -7.31%
Sep-06-17 08:30AM  Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
08:00AM  2017 is a Transformative Year for Synergy, Q2 Review, and Analyst Outlook ACCESSWIRE
Sep-05-17 08:30AM  Synergy Pharmaceuticals Secures $300 Million Debt Financing Business Wire
Aug-11-17 08:40PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : August 12, 2017 Capital Cube
Aug-10-17 11:19AM  Here's Why Synergy Pharmaceuticals Inc. Is Falling Today Motley Fool -13.03%
08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Synergy Pharmaceuticals Inc is a negative sign for its shares Markit
Aug-09-17 04:30PM  Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update Business Wire
Aug-08-17 02:58PM  Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why? Motley Fool -7.27%
Jul-28-17 09:35AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : July 28, 2017 Capital Cube
Jul-25-17 01:11PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 25, 2017 Capital Cube
Jul-24-17 07:09PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 24, 2017 Capital Cube
Jul-14-17 04:48PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 14, 2017 Capital Cube
Jul-13-17 04:07PM  What To Expect Ahead of Synergy Pharmaceuticals Inc (SGYP) 2Q Earnings; Oppenheimers Take SmarterAnalyst
Jul-10-17 01:41PM  Synergy Pharmaceuticals Inc (SGYP) Trulance Poses Enticing Long-Term Uptake SmarterAnalyst
Jun-27-17 11:55AM  Healthcare Guru Samuel Isaly Plays Two Key Biotech Stocks: Synergy Pharmaceuticals Inc (SGPY), Gilead Sciences, Inc. (GILD) SmarterAnalyst -5.18%
Jun-26-17 06:41PM  Synergy Pharmaceuticals Incs (SGYP) CIC Drug Set To Stay In Spotlight; BTIG Weighs In SmarterAnalyst
Jun-20-17 03:42PM  Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock Motley Fool
Jun-15-17 03:17PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : June 15, 2017 Capital Cube
Jun-14-17 02:18PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : June 14, 2017 Capital Cube
Jun-13-17 08:37AM  Rodman & Renshaw Roots for Synergy Pharmaceuticals Inc. (SGYP) Ahead of Promising Commercial Trajectory for Trulance SmarterAnalyst
08:26AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : June 13, 2017 Capital Cube
Jun-12-17 12:40PM  Billionaire Israel Izzy Englander Bets on Three Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP) SmarterAnalyst
Jun-07-17 09:00AM  Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application (sNDA) for TRULANCE (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Jun-05-17 09:01AM  Is Ironwood's Growth About to Slow? Motley Fool -5.25%
08:00AM  Today's Research Reports on Stocks to Watch: Synergy Pharmaceuticals and Bioscrip Inc. Accesswire
Jun-03-17 11:13AM  Here's the Volatile Biotech Stock One Analyst Thinks Could Boom 175% TheStreet.com
Jun-02-17 01:03PM  Why Synergy Pharmaceuticals Shares Are Popping 16.7% Today Motley Fool +10.19%
May-30-17 08:30AM  Synergy Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Business Wire
May-29-17 01:32PM  With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory? Motley Fool
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks -6.33%
May-15-17 04:59PM  What Do the Ardelyx Numbers Mean for the Company? GuruFocus.com -8.31%
08:00AM  Synergy Pharmaceuticals and Durect Corporation Both Sail Higher on Trader Optimism Accesswire
May-10-17 06:44PM  Synergy Pharma reports 1Q loss Associated Press
04:54PM  Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update Business Wire
May-09-17 11:46AM  Synergy Scores Again: Trulance Product Meets Phase 3 Endpoints In Second Indication Benzinga
11:45AM  Synergy Pharmaceuticals to Present Positive TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
May-07-17 10:30AM  Synergy Presents New Insights at Digestive Disease Week (DDW) Examining Patient and Physician Perceptions and Experiences with Chronic Idiopathic Constipation (CIC) Business Wire
10:30AM  Synergy Pharmaceuticals to Present TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Adults with Chronic Idiopathic Constipation (CIC) with Moderate to Very Severe Bloating Business Wire
May-01-17 08:00AM  Synergy Pharmaceuticals to Highlight New Data for TRULANCE (Plecanatide) at Digestive Disease Week (DDW) Business Wire
Apr-24-17 08:00AM  Synergy Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Healthcare Conference Business Wire
Apr-17-17 08:00AM  Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer Business Wire
Apr-13-17 09:21AM  Biotech Movers: Synergy, Biogen, Insys TheStreet.com
Apr-12-17 09:32AM  Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents TheStreet.com
08:00AM  Synergy Pharmaceuticals Announces Issuance of Three New Patents Expected to Extend TRULANCE (Plecanatide) Patent Protection Until 2032 Business Wire
Apr-06-17 08:46PM  [$$] Overheard The Wall Street Journal -5.32%
10:56AM  Drug Company's New Poop Emojis Make a Splash The Wall Street Journal
10:32AM  Trevena, Synergy Lead Biotech Movers TheStreet.com
09:06AM  Synergy Pharmaceuticals Launches the Poop Troop, the First Emoji Keyboard Designed to Support Dialogue Around Chronic Idiopathic Constipation (CIC) Business Wire
Mar-30-17 07:14AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Synergy Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-27-17 08:31AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Synergy Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for TRULANCE (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Mar-21-17 02:46PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -8.64%
Mar-14-17 09:32AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare Conference Business Wire
Mar-13-17 09:29AM  Synergy Pharmaceuticals: Approval, Now What? Motley Fool
Mar-07-17 01:04PM  SYNERGY PHARMACEUTICALS, INC. Financials
Mar-02-17 04:45PM  CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update Business Wire -5.46%
04:02PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Mar-01-17 05:15PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
05:12PM  Synergy Pharma reports 4Q loss Associated Press
04:42PM  Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update Business Wire
Feb-23-17 11:07AM  Did 50 Salespeople Leave Valeant? Wells Fargo Investigates Barrons.com
10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks at Insider Monkey
Feb-15-17 10:37AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-08-17 10:42AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global Healthcare Conference Business Wire
Feb-07-17 12:31PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAULSON & CO. INC.10% OwnerNov 10Sale2.828,750,00024,678,50015,312,368Nov 14 04:36 PM
PAULSON & CO. INC.10% OwnerAug 07Sale3.7726,28798,97224,062,368Aug 09 06:17 PM
BRANCACCIO JOHN PDirectorMay 26Buy3.596,50023,33530,444May 30 07:56 AM
JACOB GARY SChief Executive OfficerMay 26Buy3.525,68019,967402,679May 30 07:55 AM